Nik Drugs & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.95 M
as on 17-12-2024
- Paid Up Capital ₹ 0.78 M
as on 17-12-2024
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 70.10%
(FY 2022)
- Profit 7435.54%
(FY 2022)
- Ebitda 154.88%
(FY 2022)
- Net Worth 3.32%
(FY 2022)
- Total Assets -3.88%
(FY 2022)
About Nik Drugs & Chemicals
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.95 M and a paid-up capital of Rs 0.78 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Agrawal and Niket Agrawal serve as directors at the Company.
- CIN/LLPIN
U24232MP1989PTC005299
- Company No.
005299
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 1989
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nik Drugs & Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niket Agrawal  | Director | 31-Aug-2018 | Current |
| Ravindra Agrawal | Director | 11-Nov-1993 | Current |
Financial Performance of Nik Drugs & Chemicals.
Nik Drugs & Chemicals Pvt Ltd., for the financial year ended 2022, experienced significant growth in revenue, with a 70.1% increase. The company also saw a substantial improvement in profitability, with a 7435.54% increase in profit. The company's net worth moved up by a moderate rise of 3.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nik Drugs & Chemicals?
Unlock access to Nik Drugs & Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kin Drugs & Chemicals Pvt Ltd.Active 35 years 6 monthsRavindra Agrawal and Niket Agrawal are mutual person
- Ravikiran Textiles Pvt. Ltd.Active 35 years 4 months
Ravindra Agrawal and Niket Agrawal are mutual person
- R.K.Rasayan Private LimitedActive 28 years 8 months
Ravindra Agrawal and Niket Agrawal are mutual person
- Ravikiran Rasayan Distributors Pvt. Ltd.Active 35 years 4 months
Ravindra Agrawal and Niket Agrawal are mutual person
- Kiran Land Skapers Pvt.Ltd.Active 33 years 7 months
Ravindra Agrawal and Niket Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nik Drugs & Chemicals?
Unlock and access historical data on people associated with Nik Drugs & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nik Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nik Drugs & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
